Abstract
No public abstract is available from the verified source records.
Giovanni Gotte
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease
10.1073/pnas.91.8.2915 · 1994
BS-RNase tetramers: an example of domain-swapped oligomers
10.1016/s0014-5793(96)01034-4 · 1996
Principles that govern the folding of protein chains
10.1126/science.181.4096.223 · 1973
Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases
10.1016/s0021-9258(18)52427-3 · 1991
Human pancreatic ribonuclease
10.1111/j.1432-1033.1997.t01-1-00465.x · 1997
Biological function of pancreatic ribonuclease
10.1038/221340a0 · 1969
Inhibition of tumor cell proliferation by dimerized ribonuclease
10.1073/pnas.73.2.573 · 1976
Pancreatic ribonuclease: enzymic and physiological properties of a cross-linked dimer
10.1126/science.186.4162.444 · 1974
The amino acid sequence of human pancreatic ribonuclease
10.1016/0003-2697(84)90306-3 · 1984
Domain swapping: entangling alliances between proteins
10.1073/pnas.91.8.3127 · 1994
Deposition diseases and 3D domain swapping
10.1016/j.str.2006.03.011 · 2006
3D domain swapping: a mechanism for oligomer assembly
10.1002/pro.5560041202 · 1995
Crystal structure of eosinophil cationic protein at 2.4A resolution
10.1021/bi9919145 · 1999
Reverse transphosphorylation by ribonuclease a needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme
10.1016/s0021-9258(17)41977-6 · 1994
The antipathogen activities of eosinophil cationic protein
10.2174/138920108784567353 · 2008
New muteins of RNase A with enhanced antitumor action
10.1016/s0014-5793(98)01221-6 · 1998
The antitumor action of seminal ribonuclease and its quaternary conformations
10.1016/0014-5793(94)01450-f · 1995
The structure of an engineered domain-swapped ribonuclease dimer and its implications for the evolution of proteins toward oligomerization
10.1016/s0969-2126(01)00659-1 · 2001
Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein
10.1021/bi0273011 · 2003
Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation
10.1007/s11010-005-4777-2 · 2005
Cellular uptake of ribonuclease a relies on anionic glycans
10.1021/bi1013485 · 2010
Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase
10.1080/07357900500283143 · 2005
Elucidation of the ribonuclease a aggregation process mediated by 3D domain swapping: a computational approach reveals possible new multimeric structures
10.1002/bip.20833 · 2008
On the aggregation of bovine pancreatic ribonuclease
1962
On the preparation of bovine pancreatic ribonuclease A
10.1016/s0021-9258(18)81307-2 · 1963
Bull semen ribonucleases: 1. Purification and physico-chemical properties of the major component
10.1111/j.1432-1033.1972.tb01751.x · 1972
Dimeric structure of seminal ribonuclease
10.1016/0014-5793(72)80642-2 · 1972
Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 melanoma cells correlates with the downregulation of specific onco-proteins
10.3390/ijms23031647 · 2022
Structural determinants of enzymic processivity
10.1021/bi00186a001 · 1994
A residue to residue hydrogen bond mediates the nucleotide specificity of ribonuclease A
10.1006/jmbi.1995.0500 · 1995
Ribonuclease A can be transformed into a dimeric ribonuclease with antitumor activity
10.1016/s0021-9258(17)32451-1 · 1994
A new mutant of bovine seminal ribonuclease with a reversed swapping propensity
10.1021/bi0613630 · 2007
Comparison of the structural and functional properties of RNase A and BS-RNase: a stepwise mutagenesis approach
10.1002/bip.21176 · 2009
Acidity generated by the tumor microenvironment drives local invasion
10.1158/0008-5472.can-12-2796 · 2013
Extensive deamidation of RNase A inhibits its oligomerization through 3D domain swapping
10.1016/j.bbapap.2016.10.008 · 2017
Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells*
10.1042/bcj20170541 · 2017
Dimerization of human angiogenin and of variants involved in neurodegenerative diseases
10.3390/ijms221810068 · 2021
The Destabilizing Effect Of Ribonuclease On The Helical Dna Structure
10.1073/pnas.50.4.644 · 1963
Interaction of platinum-based drugs with proteins: an overview of representative crystallographic studies
10.2174/18734294mta3bnjea5 · 2021
Cytotoxicity and binding to DNA, lysozyme, ribonuclease a, and human serum albumin of the diiodido analog of picoplatin
10.1021/acs.inorgchem.4c05424 · 2025
Two distinct secretory ribonucleases from human cerebrum: purification, characterization and relationships to other ribonucleases
10.1042/bj2960617 · doi-reference
Rosenthal fibers, eosinophilic inclusions, and anchorage densities with desmosome-like structures in astrocytes in Alzheimer's disease
10.1007/bf00313604 · doi-reference
Preparation of cross-linked dimers of pancreatic ribonuclease
10.1021/bi00648a033 · doi-reference
Polyspermine-ribonuclease prepared by cross-linkage with dimethyl suberimidate
10.1021/bi00632a021 · doi-reference
RNase A oligomerization through 3D domain swapping is favoured by a residue located far from the swapping domains
10.1016/j.biochi.2011.07.005 · doi-reference
Zero-Length dimers of ribonuclease a: further characterization and no evidence of cytotoxicity
10.1021/bc900407v · doi-reference
A phase II trial of weekly intravenous ranpirnase (Onconase®), a novel ribonuclease in patients with metastatic kidney cancer
10.1023/a:1010633004157 · doi-reference
Eosinophil cationic protein (ECP)
10.1016/s1357-2725(97)00127-1 · doi-reference
Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptake
10.1007/s002800050962 · doi-reference
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
10.1002/ana.22611 · doi-reference
Interaction of onconase with the human ribonuclease inhibitor protein
10.1016/j.bbrc.2008.10.032 · doi-reference
Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region
10.1021/bm100334u · doi-reference
Amino acid sequence of sialic acid binding lectin from frog (Rana catesbeiana) eggs
10.1021/bi00382a018 · doi-reference
Value of general acid-base catalysis to ribonuclease A
10.1021/ja00091a060 · doi-reference
Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor
10.1261/rna.065516.117 · doi-reference
Ribonuclease A suggests how proteins self-chaperone against amyloid fiber formation
10.1002/pro.754 · doi-reference
Complete amino-acid sequence of bovine seminal ribonuclease, a dimeric protein from seminal plasma
10.1515/bchm3.1987.368.2.1305 · doi-reference
Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes
10.1021/bi400619m · doi-reference
Onconase action on tRNALys3, the primer for HIV-1 reverse transcription
10.1016/j.bbrc.2007.08.157 · doi-reference
The angiogenins
10.1007/s000180050210 · doi-reference
The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins
10.1016/j.febslet.2010.04.018 · doi-reference
Human extracellular ribonucleases: multiplicity, molecular diversity and catalytic properties of the major RNase types
10.1007/s000180050207 · doi-reference
Human pancreatic-type and nonpancreatic-type ribonucleases: a direct side-by-side comparison of their catalytic properties
10.1006/abbi.1994.1318 · doi-reference
Carrier protein-modulated presentation and recognition of an N-glycan: observations on the interactions of Man8 glycoform of ribonuclease B with conglutinin
10.1093/glycob/11.1.31 · doi-reference
The sequence of amino acid residues in bovine pancreatic ribonuclease: revisions and confirmations
10.1016/s0021-9258(19)83984-4 · doi-reference
Genetic selection for critical residues in ribonucleases
10.1016/j.jmb.2006.07.020 · doi-reference
Motoneurons secrete angiogenin to induce RNA cleavage in astroglia
10.1523/jneurosci.6366-11.2012 · doi-reference
A novel cross-linked RNase A dimer with enhanced enzymatic properties
10.1002/prot.21144 · doi-reference
Structure of angiogenin dimer bound to double-stranded RNA
10.1107/s2053230x22008317 · doi-reference
The multiple forms of bovine seminal ribonuclease: structure and stability of a C-terminal swapped dimer
10.1016/j.febslet.2013.10.003 · doi-reference
Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma
10.1093/abbs/gmw082 · doi-reference
Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. alanine derivatives inhibit angiogenin-induced angiogenesis
10.1021/bi00444a038 · doi-reference
Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily
10.1016/s0021-9258(19)36710-9 · doi-reference
Atomic structures of amyloid cross-β spines reveal varied steric zippers
10.1038/nature05695 · doi-reference
Amyloid-like fibrils of ribonuclease a with three-dimensional domain-swapped and native-like structure
10.1038/nature03916 · doi-reference
Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease
10.1093/jnci/88.11.747 · doi-reference
Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity
10.2174/138920108784567344 · doi-reference
Antitumor activity of ribonuclease multimers created by site-specific covalent tethering
10.1021/bc100292x · doi-reference
In vitro evolution of a dimeric variant of human pancreatic ribonuclease
10.1021/bi992367q · doi-reference
Recombinant human eosinophil cationic protein: ribonuclease activity is not essential for cytotoxicity
10.1074/jbc.270.14.7876 · doi-reference